PEAK6 Investments’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

PEAK6 Investments’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-139,898	Closed	-$1.4M	–	5539
2022 Q3	$1.4M	Buy	+139,898	New	+$1.39M	0.01%	1889
2022 Q2	–	Sell	-139,899	Closed	-$1.38M	–	6041
2022 Q1	$1.38M	Hold	139,899	–	–	﹤0.01%	2195
2021 Q4	$1.36M	Hold	139,899	–	–	﹤0.01%	2283
2021 Q3	$1.37M	Hold	139,899	–	–	﹤0.01%	2323
2021 Q2	$1.36M	Hold	139,899	–	–	﹤0.01%	2266
2021 Q1	$1.39M	Buy	+139,899	New	+$1.43M	﹤0.01%	2247

PEAK6 Investments's FLAC Position: Q4 2022 in Review

PEAK6 Investments sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 139,898 shares — an estimated $1.4M sold.

PEAK6 Investments first reported a position in FLAC in Q1 2021 and held it in 6 quarters. The position peaked at $1.4M in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

PEAK6 Investments reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
PEAK6 Investments sold 139,898 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $1.4M.
PEAK6 Investments first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and held it in 6 quarters.
PEAK6 Investments's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $1.4M in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on PEAK6 Investments's 13F filing for Q4 2022, filed 10 Feb 2023.